Hope for stubborn hypertension: trial tests new drug to protect blood vessels
NCT ID NCT04388124
Summary
This study is testing if adding a new type of drug (an endothelin receptor blocker) can improve blood vessel health and help control blood pressure in people whose high blood pressure remains high despite taking three medications. Researchers will measure how well blood vessels relax and function, and check the drug's safety, especially for the kidneys. The trial will include 24 adults with confirmed resistant hypertension.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for RESISTANT HYPERTENSION are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Chu Rouen
RECRUITINGRouen, 76031, France
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Conditions
Explore the condition pages connected to this study.